The U.S. FDA recently approved FluMist as a self or caregiver-administered nasal spray flu vaccine to prevent Influenza ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

Most respiratory viruses, like the flu and COVID-19, enter the body through the nose. When an infected person exhales, ...

Gaithersburg, Maryland-based MedImmune has received the FDA’s approval of its FluMist nasal spray flu vaccine, meaning no ...

The FDA has approved a nasal spray flu vaccine for home use. Here's how it works, and when it will be available.

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver ...

FluMist contains a weakened form of live flu virus strains and is sprayed into the nose. “The nasal spray is a live vaccine ...

Sept. 23, 2024 – The FDA on Friday approved FluMist, a nasal spray flu vaccine that you or a caregiver can now give at home – no health care provider needed. It’s the first flu vaccine of ...

The arrival of spring is traditionally associated with allergies, but the crisp air brought on by autumn's cooler weather ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.

FluMist Home, like the original version administered in medical offices and pharmacies, is for adults under age 50 and kids 2 ...